"Decadose" Effects of Cisplatin on Squamous Cell Carcinoma of the Upper Aerodigestive Tract. II. Clinical Studies

Laryngoscope

Volumn 106, Issue 1 I, 1996, Pages 37-42

  Robbins, K Thomas ^a,b,c   Storniolo, Anna Maria ^a,b   Hryniuk, William M ^a,b   Howell, Stephen B ^a,b  

^a West Indies

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; THIOSULFATE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOTOXICITY; DIGESTIVE SYSTEM; DOSE RESPONSE; DRUG EXPOSURE; DRUG UPTAKE; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 0030062961     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199601000-00008     Document Type: Article

References (27)

1. Bier, H., Bergler, W., Mickisch, G., et al.: Establishment and Characterization of Cisplatin-Resistant Sublines of the Human Squamous Carcinoma Cell Line HLac 79. Acta Otolaryngol (Stockh), 110:466-473, 1990.
2. Behrens, B.C., Grotzinger, K.R., Hamilton, T.C., et al.: Cytotoxicity of 3 Cisplatin Analogues in a Drug Sensitive and a New Cisplatin Resistant Human Ovarian Cancer Cell Line. Proc Am Assoc Cancer Res, 26:262. 1985. Abstract.
3. Levin, L. and Hryniuk, W.: Dose Intensity Analysis of Chemotherapy Regimens in Ovarian Carcinoma. J Clin Oncol, 5: 756-767, 1987.
4. Lippman, A.J., Helson, C., Helson, L., et al.: Clinical Trials of cis-Diamminedichloroplatinum (NSC-119875). Cancer Chemother Rep, 57:191-200, 1973.
5. Hayes, D.M., Cvitkovic, E., Golbey, R.B., et al.: High Dose cis-Platinum Diammine Dichloride. Cancer, 39:1372-1381, 1977.
6. Ozols, R.F., Corden, B.J., Jacob, J., et al.: High-Dose Cisplatin in Hypertonic Saline. Ann Intern Med, 100:19-24, 1984.
7. Randolph, V.L., Vallejo, A., Spiro, R.H., et al.: Combination Therapy of Advanced Head and Neck Cancer: Induction of Remissions With Diamminedichloroplatinum (II), bleomycin and radiotherapy. Cancer, 41:460-467, 1978.
8. Hayat, M., Bayssas, M., Brule, G., et al.: Cis-Platinum-Diammino-Dichlor (CPID) in Chemotherapy of Cancers: Phase II Therapeutic Trial. Biochimie, 60:935-940, 1978.
9. Wittes, R., Heller, K., Randolph, V., et al: cis-Dichlorodiammineplatinum (II)-Based Chemotherapy As Initial Treatment of Advanced Head and Neck Cancer. Cancer Treat Rep, 63:1533-1538, 1979.
10. Al-Sarraf M.: Chemotherapy Strategies in Squamous Cell Carcinoma of the Head and Neck. CRC Crit Rev Oncolo Hematol, 1:323-355, 1982.
11. Frustaci, S., Barzan, L. Carusco, G., et al.: Induction Intra-arterial Cisplatin and Bleomycin in Head and Neck Cancer. Head Neck, 13:291-297, 1991.
12. Mortimer, J.E., Taylor, M.E., Schulman, S., et al.: Feasibility and Efficacy of Weekly Intraarterial Cisplatin in Locally Advanced (stage III and IV) Head and Neck Cancers. J Clin Oncol, 6:969-975, 1988.
13. Galmarini, F.C., Yoek, H., Abulaafia, J., et al.: Intra-arterial Cisplatinum in Head and Neck Cancer: Controlled Clinical Trial in Phases I and II. Head Neck Surg, 3:257, 1981. Abstract.
14. Cheung, D.K., Regan, J., Savin, M., et al.: A Pilot Study of Intraarterial Chemotherapy With Cisplatin in Locally Advanced Head and Neck Cancers. Cancer, 61:903-908, 1988.
15. Claudio, F., Rotondi, M., Bonassi, S., et al.: Factors Affecting Response and Survival in Advanced Head and Neck Cancers Treated With Intraarterial Chemotherapy. Reg Cancer Treat, 4:180-187, 1992.
16. Forastiere, A.A., Baker, S.R., Wheeler, R., et al.: Intra-arterial Cisplatin and FUDR in Advanced Malignancies Confined to the Head and Neck. J Clin Oncol, 5:1601-1606, 1987.
17. Lee, Y.Y., Dimery, I., Van Tassel, P., et al.: Superselective Intraarterial Chemotherapy of Advanced Paranasal Sinus Tumors. Arch Otolaryngol Head Neck Surg, 115:503-511, 1989.
18. Molinari, R.: Preliminary Intra-arterial Chemotherapy in Cancer of the Oral Cavity: Long-term Results of Combined Treatments With Surgery and Radiotherapy. P.B. Cretian, M.E. Johns, D.P. Shedd, et al. (Eds.). In: Head and Neck Cancer. Marcel Decker, Philadelphia, pp. 456-461, 1985.
19. Wolpert, S.M., Kwan, E.S., Heros, D., et al.: Selective Delivery of Chemotherapeutic Agents With a New Catheter System. Radiology, 166:547-549, 1988.
20. Eckman, W.W., Patlak, C.S. and Fenstermacher, J.D.: A Critical Evaluation of the Principles Governing the Advantages of Intra-arterial Infusions. J Pharmacokinet Biopharm, 2: 257-285, 1974.
21. Wheeler, R.H., Ziessman, H.A., Medvec, B.R., et al.: Tumor Blood Flow and Systemic Shunting in Patients Receiving Intraarterial Chemotherapy for Head and Neck Cancer. Cancer Res. 46:4200-4204, 1986.
22. Forastiere, A.A., Takasuri, B.J., Baker, S.R., et al.: High-Dose Cisplatin in Advanced Head and Neck Cancer. Cancer Chemother Pharmacol, 19:155-158, 1987.
23. Haines, I., Bosl, G., Pfister, D., et al: Very-High-Dose Cisplatin With Bleomycin Infusion As Initial Treatment of Advanced Head and Neck Cancer. J Clin Oncol, 5:1594-1600, 1987.
24. Kish, J.A., Ensley, J.F., Jacobs, J.R., et al.: Evaluation of High-dose Cisplatin and 5-FU Infusion As Initial Therapy in Advanced Head and Neck Cancer. Am J Clin Oncol, 2:553-557, 1988.
25. Elferink, W.J.F., van der Vijah, I.K. and Pinedo, H.M.: Interaction of Cisplatin and Carboplatin With Sodium Thiosulfate: Reaction Rates and Protein Binding. Clin Chem, 32:642-645, 1986.
26. Shea, M., Koziol, J.A. and Howell, S.B.: Kinetics of Sodium Thiosulfate, a Cisplatin Neutralizer. Clin Pharmacol Ther, 35:419-425, 1984.
27. Robbins, KT, Storniolo, A.M.S., Kerber, C., et al.: Phase I Study of Highly Selective Supradose Cisplatin Infusions for Advanced Head and Neck Cancer. J Clin Oncol, 12:2113-2120, 1994.